Home > Insider Trading > Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc. (DNA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds

The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics, digital therapeutics...

Keep Reading →

October 30th, 2024 - Hedge Funds Industries News

10 High Risk High Reward Growth Stocks Stocks To Buy

When it comes to making money on the stock market, most investors are typically attracted to growth stocks.

Keep Reading →

September 9th, 2024 - Market Movers News

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2024 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q2 2024 Earnings Call Transcript August 8, 2024Ginkgo Bioworks Holdings, Inc. misses on earnings expectations.

Keep Reading →

August 9th, 2024 - News Transcripts

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2024 Earnings Call Transcript

Megan LeDuc: Good evening, I’m Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I’m joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.

Keep Reading →

May 10th, 2024 - News Transcripts

16 Best US Stocks To Invest In Under $10

In March 2024, the S&P 500 surged with a total return of 3.2%, marking the first quarter's closure with a record high not seen since 2019.

Keep Reading →

May 7th, 2024 - Hedge Funds Lists News

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2023 Earnings Call Transcript

Ginkgo Bioworks Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.09 EPS, expectations were $-0.09. Ginkgo Bioworks Holdings, Inc.

Keep Reading →

March 2nd, 2024 - News Transcripts